2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital ...

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...

D r. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

BioMarin Pharmaceutical ( BMRN +1.56%) reported its third-quarter earnings after market close Monday, and they were good enough to push the biotech stock almost 2% higher the following day. With that ...

Virginia will be home to a workforce training center preparing thousands of people each year for a career in the pharmaceutical industry.

Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...

Health Biotech Limited, an Indian pharmaceutical company, successfully showcased its innovative products at CPHI Frankfurt 2025, a notable global pharmaceutical event. The company, celebrated for its ...

Novo Nordisk asserts its acquisition of Metsera won't pose antitrust problems as it competes with Pfizer for dominance in the ...